Industries > Pharma > Pharma Wholesale and Distribution Market Forecasts 2017-2027

Pharma Wholesale and Distribution Market Forecasts 2017-2027

Branded and Generic Drug Distribution, Leading National Markets, Leading Wholesalers, US, Europe, Japan and China

PUBLISHED: 22 June 2017
PAGES: 265
PRODUCT CODE: PHA0205

Clear
WOOCS 2.2.1
SKU: PHA0205 Categories: , ,

The pharma wholesale and distribution market is estimated at $893.69 million in 2016 and is expected to grow at a CAGR of 6.0% in the first half of the forecast period. The market is expected to grow at a CAGR of 5.2% from 2017-2027. In 2016, the branded drugs submarket held 79.5% share of the pharma wholesale and distribution market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 265-page report you will receive 83 tables and 97 figures – all unavailable elsewhere.

The 265-page report provides clear detailed insight into the pharma wholesale and distribution market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

Pharma Wholesale and Distribution market forecasts from 2017-2027

• This report also breaks down the revenue forecast for main submarkets:
– Branded Drugs
– Generic Drugs
– Other Medicines

• This report provides individual revenue forecasts to 2027 for these national markets:
– The US
– Japan
– Germany
– France
– Italy
– Spain
– The UK
– China
– Brazil
– Russia
– India

Pharma Wholesale and Distribution Market Forecasts 2017-2027

• Our study includes SWOT and STEP analysis of this industry and market.

• Our study discusses the selected leading companies that are the major players in the pharma wholesale and distribution industry:
– McKesson
– Cardinal Health
– AmerisourceBergen
– Walgreens Boots Alliance
– MEDIPAL HOLDINGS
– The PHOENIX Group
– SINOPHARM
– Alfresa Holdings
– SUZUKEN
– Shanghai Pharmaceutical Holdings

• Our report explains issues, events and shifts affecting that industry and market from 2016, including these influences:
– Roles of pharmaceutical wholesalers – activities, changes and prospects
– Revenues, costs and profits
– Direct-to-pharmacy (DTP) activities
– Full-line wholesalers (FLWs), short-line wholesalers (SLWs) and the drug distribution chain, including logistical service providers
– Technologies and services – progress in supplying pharmacies, clinics and hospitals, serving healthcare professionals, governments, payers and patients
– Forward buying, fee-for-service systems and the rise of retail pharmacies.

• Our investigation also discusses other aspects of that industry, including these forces:
– Parallel trade – activities, policies, challenges and effects
– Inventory management agreements, clawback, reimbursement and discounts
– Rise of specialty medicines, including biologics, vaccines and biosimilars – opportunities for intermediaries, including cold chain distribution networks
– Actions against drug counterfeiting – security of pharmaceutical supply chains
– Changes to regulations and healthcare budgets – policies affecting trade

Visiongain’s study is intended for anyone requiring commercial analyses for the pharma wholesale and distribution market. You find data, trends and predictions.

Buy our report today Pharma Wholesale and Distribution Market Forecasts 2017-2027: Branded and Generic Drug Distribution, Leading National Markets, Leading Wholesalers, US, Europe, Japan and China.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Pharma Wholesale and Distribution Market Forecasts 2017-2027


Download sample pages

Complete the form below to download your free sample pages for Pharma Wholesale and Distribution Market Forecasts 2017-2027


Latest Pharma news

Visiongain Publishes Clinical Trial Supplies Market Report 2021-2031

Deviating from protocols raises the danger of missing or delaying data collection from current investigations. This highlights the growing importance of digital medicine, which is being aided by advancements in cloud, mobile, and IoT technology.

11 October 2021

READ

Visiongain Publishes Drug Discovery Informatics Market Report 2021-2031

High performance HPC and supercomputing technology have evolved substantially in China in the last decades, leading to extraordinary accomplishments. HPC-based and combined pharmaceutical chemical and computational biology computational discovery and design has become a significant technique in drug research and development and is sponsored financially by the Chinese government.

07 October 2021

READ

Visiongain Publishes Pharma Wholesale and Distribution Market Report 2021-2031

Many health-care organizations are seeing organic growth at levels that their supply networks were never designed to handle. Others are frantically attempting to integrate diverse technology and procedures as part of a consolidation effort.

06 October 2021

READ

Visiongain Publishes Meningococcal Vaccines Market Report 2021-2031

Rise in prevalence of meningitis, increasing initiatives by government and regulatory authorities coupled strong funding support from non-profit organizations is expected to drive the global meningococcal vaccines market

05 October 2021

READ

Categories